Currency in INR
| Earnings estimate | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
|---|
| No. of analysts | 1 | 1 | 14 | 14 |
| Avg. Estimate | 11.62 | 12.78 | 46 | 40.94 |
| Low estimate | 11.62 | 12.78 | 40.7 | 21.63 |
| High estimate | 11.62 | 12.78 | 63.1 | 54.57 |
| Year ago EPS | 5.58 | 4.82 | 39.13 | 46 |
| Revenue estimate | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
|---|
| No. of analysts | 1 | 1 | 14 | 14 |
| Avg. Estimate | 6.1B | 6.5B | 25.06B | 25.8B |
| Low estimate | 6.1B | 6.5B | 23.64B | 20.25B |
| High estimate | 6.1B | 6.5B | 30.59B | 29.88B |
| Year ago sales | 4.28B | 4.27B | 21.85B | 25.06B |
| Sales growth (year/est) | 42.50% | 52.30% | 14.70% | 3.00% |
| Earnings history | 30/06/2017 | 30/09/2017 | 31/12/2017 | 31/03/2018 |
|---|
| Est. EPS | 4 | 3.89 | 18 | 17.1 |
| Actual EPS | 5.58 | 4.82 | 12.25 | 16.21 |
| Difference | 1.58 | 0.93 | -5.75 | -0.89 |
| Surprise % | 39.50% | 23.90% | -31.90% | -5.20% |
| EPS trend | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
|---|
| Current estimate | 11.62 | 12.78 | 46 | 40.94 |
| 7 days ago | 11.62 | 12.78 | 46 | 40.94 |
| 30 days ago | 10.13 | 9.47 | 46.92 | 42.27 |
| 60 days ago | 10.13 | 9.47 | 47 | 41.94 |
| 90 days ago | 10.13 | 9.47 | 46.99 | 41.94 |
| EPS revisions | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | 1 | 1 | 4 | 3 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | NATCOPHARM.BO | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | 108.20% | N/A | N/A | N/A |
| Next qtr. | 165.10% | N/A | N/A | N/A |
| Current year | 17.60% | N/A | N/A | N/A |
| Next year | -11.00% | N/A | N/A | N/A |
| Next 5 years (per annum) | 24.00% | N/A | N/A | N/A |
| Past 5 years (per annum) | 60.39% | N/A | N/A | N/A |
